BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Cristofaro R, Liuzzo G, Sacco M, Lancellotti S, Pedicino D, Andreotti F. Marked von Willebrand factor and factor VIII elevations in severe acute respiratory syndrome coronavirus-2-positive, but not severe acute respiratory syndrome coronavirus-2-negative, pneumonia: a case-control study. Blood Coagul Fibrinolysis 2021;32:285-9. [PMID: 33443926 DOI: 10.1097/MBC.0000000000000998] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Alavi P, Rathod AM, Jahroudi N. Age-Associated Increase in Thrombogenicity and Its Correlation with von Willebrand Factor. J Clin Med 2021;10:4190. [PMID: 34575297 DOI: 10.3390/jcm10184190] [Reference Citation Analysis]
2 Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol 2021;164:69-82. [PMID: 34838588 DOI: 10.1016/j.yjmcc.2021.11.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
3 Shimura T, Kurano M, Kanno Y, Ikeda M, Okamoto K, Jubishi D, Harada S, Okugawa S, Moriya K, Yatomi Y. Clot waveform of APTT has abnormal patterns in subjects with COVID-19. Sci Rep 2021;11:5190. [PMID: 33664450 DOI: 10.1038/s41598-021-84776-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Becker RC, Sexton T, Smyth S; International COVID-19 Thrombosis Biomarkers Colloquium (ICODE) Investigators. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. J Thromb Thrombolysis 2021. [PMID: 34350541 DOI: 10.1007/s11239-021-02544-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Sacco M, Tardugno M, Lancellotti S, Ferretti A, Ponziani FR, Riccardi L, Zocco MA, De Magistris A, Santopaolo F, Pompili M, De Cristofaro R. ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portavein thrombosis in compensated cirrhosis. A prospective observational study. Dig Liver Dis 2022:S1590-8658(22)00543-6. [PMID: 35778228 DOI: 10.1016/j.dld.2022.06.004] [Reference Citation Analysis]
6 Sinkovits G, Réti M, Müller V, Iványi Z, Gál J, Gopcsa L, Reményi P, Szathmáry B, Lakatos B, Szlávik J, Bobek I, Prohászka ZZ, Förhécz Z, Mező B, Csuka D, Hurler L, Kajdácsi E, Cervenak L, Kiszel P, Masszi T, Vályi-Nagy I, Prohászka Z. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality. Thromb Haemost 2022. [PMID: 35062036 DOI: 10.1055/s-0041-1740182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Bray M, Guzel MA, Lam F, Yee A, Cruz MA, Rumbaut RE. High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19. J Thromb Thrombolysis 2022. [PMID: 35881214 DOI: 10.1007/s11239-022-02679-5] [Reference Citation Analysis]
8 Gorog DA, Storey RF, Gurbel PA, Tantry US, Berger JS, Chan MY, Duerschmied D, Smyth SS, Parker WAE, Ajjan RA, Vilahur G, Badimon L, Berg JMT, Cate HT, Peyvandi F, Wang TT, Becker RC. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium. Nat Rev Cardiol 2022. [PMID: 35027697 DOI: 10.1038/s41569-021-00665-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 17.0] [Reference Citation Analysis]